COGT - Cogent Biosciences, Inc.

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-69.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-968%)	-83.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1140%)	130.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1529%)	—	-50.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-726%)	88.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1004%)	—	—	-12.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-254%)	-19.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-348%)	—	—	—	—	—	—
EPS Growth YoY (%)	-1.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-22.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	21.9% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	10.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	16.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-233.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-12.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-28.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	16.9% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	N/M	-4.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-65.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-35.2% Weak ↓ Weak Declining Year-over-year change in net income	-50.9% Weak ↓ Weak Declining Year-over-year change in net income	-23.4% Weak → Weak Stable Year-over-year change in net income	-23.4% Weak ↑ Weak Improving Year-over-year change in net income	-23.4% Weak ↑ Weak Improving Year-over-year change in net income	-24.9% Weak ↑ Weak Improving Year-over-year change in net income	-51.2% Weak ↓ Weak Declining Year-over-year change in net income	-51.2% Weak ↓ Weak Declining Year-over-year change in net income	-51.2% Weak ↓ Weak Declining Year-over-year change in net income	-37.2% Weak ↓ Weak Declining Year-over-year change in net income	-26.0% Weak ↑ Weak Improving Year-over-year change in net income	-26.0% Weak ↑ Weak Improving Year-over-year change in net income	-26.0% Weak ↑ Weak Improving Year-over-year change in net income	-59.0% Weak ↑ Weak Improving Year-over-year change in net income	-161.2% Weak ↓ Weak Declining Year-over-year change in net income	-161.2% Weak ↓ Weak Declining Year-over-year change in net income	-161.2% Weak ↓ Weak Declining Year-over-year change in net income	-119.7% Weak ↓ Weak Declining Year-over-year change in net income	-92.5% Weak → Weak Stable Year-over-year change in net income	-92.5% Weak ↓ Weak Declining Year-over-year change in net income	-92.5% Weak ↓ Weak Declining Year-over-year change in net income	N/M	47.9% Excellent → Excellent Stable Year-over-year change in net income	47.9% Excellent ↑ Excellent Improving Year-over-year change in net income	47.9% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-15.0% Weak ↑ Weak Improving Year-over-year change in net income	-29.6% Weak ↑ Weak Improving Year-over-year change in net income	-73.6% Weak ↓ Weak Declining Year-over-year change in net income	-28.6% Weak ↑ Weak Improving Year-over-year change in net income	-45.3% Weak ↓ Weak Declining Year-over-year change in net income	-53.9% Weak Weak Year-over-year change in net income	-13.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	9.0% Fair Fair Year-over-year change in free cash flow	—	—	—	-6.7% Weak Weak Year-over-year change in free cash flow	—	—	—	3.4% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-48.8% Weak Weak Compound annual revenue growth over 3 years	-36.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-87.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-682%)	—	—	-335.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2339%)	-387.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2686%)	—	—	—	—	—	-307.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2151%)	-290.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2035%)	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-86.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-822%)	—	—	-372.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3205%)	-382.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3291%)	—	-497.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4247%)	—	—	—	-300.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2603%)	-282.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2450%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-112.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-378.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	-281.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.30x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.30x Good Good Free cash flow relative to reported net income Optimal: > 1x	-3.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	203.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	5.6% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.0% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	11.1% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-11.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-11.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-5.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	4.5% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-20.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-14.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-16.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-16.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-46.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-410%)	-32.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-26.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	-18.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-224%)	-15.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-13.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-12.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-11.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-17.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-15.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-10.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-9.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-5.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-5.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-4.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	27.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+83%)	-31.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-311%)	-23.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	7.2% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-52%)	-40.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-372%)	-29.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	-23.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-11.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	11.0% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	13.7% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-9%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	0.37x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-39%)	0.35x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-42%)	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-76%)	0.28x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-53%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	-164.45x Weak Weak Operating income divided by interest expense Optimal: > 5x	-71.98x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-18.04M	$-89.12M	$-81.05M	$-83.65M	$-126.00M	$-98.17M	$-97.05M	$-88.22M	$-215.80M	—	$-86.81M	$-214.32M	$-160.70M	—	$-140.57M	$-325.56M	$-191.05M	—	—	—	$-230.74M	$-242.19M	$-129.42M	$-21.34M	$-29.60M	$-37.42M	$-45.88M	$-55.86M	$-59.11M	$-55.67M	$-49.30M	$-46.73M	$-25.70M	$-28.27M	—	—	—	—
Debt / EBITDA (x)	-2.15x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.24x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.53x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.58x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Basic EPS, GAAP (USD)	$-0.53	$-0.61	$-0.50	$-0.53	$-0.52	$-0.50	$-0.64	$-0.59	$-0.62	$-0.15	$-0.64	$-0.59	$-0.55	$0.11	$-0.50	$-0.71	—	$-0.62	$-0.48	$-0.43	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.54	—	$-0.47	$-0.48	$-0.59	—	—	—	$-0.55	—	—	—	$-0.57	—	—	—	—	—	$-0.38	$-0.33	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$3.56	$3.95	$2.16	$1.36	$1.92	$2.32	$2.85	$3.41	$4.42	—	$3.52	$4.08	$3.15	—	$4.15	$4.86	$4.10	—	$4.95	$5.54	$6.10	$7.25	$-2.08	$0.62	$0.83	$4.14	$0.93	$1.30	$1.64	$2.00	$2.26	$2.57	$-6.00	$-4.79	—	—	—	—
Tangible Book Value per Share (USD)	$3.56	$3.95	$2.16	$1.36	$1.92	$2.32	$2.85	$3.41	$4.42	—	$3.52	$4.08	$3.15	—	$4.15	$4.86	$4.10	—	$4.95	$5.54	$6.10	$7.25	$-2.08	$0.62	$0.83	$4.14	$0.93	$1.30	$1.64	$2.00	$2.26	$2.57	$-6.00	$-4.79	—	—	—	—
Basic Weighted Avg Shares (shares)	162.19M	—	137.55M	114.47M	113.31M	—	110.17M	99.24M	94.80M	—	86.17M	74.75M	70.73M	—	69.58M	49.39M	—	—	39.85M	38.44M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$819.82M	$846.40M	$335.00M	$186.59M	$203.57M	$240.76M	$288.48M	$329.97M	$405.22M	—	$251.23M	$308.76M	$205.15M	—	$272.87M	$303.02M	$176.85M	—	—	—	$223.83M	$231.82M	$113.30M	$15.68M	$21.93M	$27.34M	$23.55M	$34.29M	$43.55M	$56.06M	$63.12M	$72.30M	$12.27M	$31.19M	—	—	—	—
LT Debt (USD)	$223.17M	$222.90M	$44.25M	$43.95M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$607.69M	$636.37M	$302.46M	$155.04M	$219.00M	$256.29M	$314.66M	$373.22M	$422.33M	$257.80M	$302.90M	$348.43M	$223.56M	$255.74M	$289.94M	$319.38M	$187.86M	$214.18M	$197.24M	$212.80M	$226.76M	$234.67M	$-22.17M	$19.24M	$25.70M	$31.76M	$28.62M	$39.76M	$49.29M	$60.23M	$67.53M	$76.67M	$-61.27M	$-48.85M	—	—	—	$-24.70M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$312.00K	$528.00K	$7.03M	—	$1.02M	$3.14M	$3.05M	—	$2.04M	$1.67M	—	—	$2.33M	$2.08M	—	—
Net Income, GAAP (USD)	$-97.35M	$-102.49M	$-71.99M	$-71.99M	$-71.99M	$-67.93M	$-58.35M	$-58.35M	$-58.35M	$-54.37M	$-38.59M	$-38.59M	$-38.59M	$-39.62M	$-30.63M	$-30.63M	$-30.63M	$-24.91M	$-11.73M	$-11.73M	$-11.73M	$-11.34M	$-6.09M	$-6.09M	$-6.09M	$2.30M	$-11.69M	$-11.69M	$-11.69M	$-8.61M	$-10.17M	$-9.02M	$-6.74M	$-6.69M	$-7.00M	$-5.86M	$-5.94M	—
Operating Cash Flow (USD)	$-86.88M	$-79.11M	$-64.29M	$-54.54M	$-66.51M	$-60.58M	—	—	$-52.53M	$-44.07M	—	—	$-39.52M	$-29.41M	—	—	$-28.33M	$-20.78M	$-14.11M	$-12.51M	$-11.37M	$-9.37M	—	—	$-7.89M	$-8.45M	—	—	$-11.52M	$-9.02M	—	—	—	$-6.52M	$-6.29M	—	—	—

Cogent Biosciences, Inc.

Analytical Summary

38-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare COGT with peers